1Extravasation due to vinca alkaloids
Warm compress & hyaluronidase
2Chemotherapy regimen with high emetic risk (3 Options)
1. NK1-RA+ 5HT3A + Dexamethasone
2. Netupitant/palonosetron (Akynzeo) + Dexamethasone
3. Olanzapine + Palonosetron + Dexamethasone
3Chemotherapy regimen with medium emetic risk (4 Options)
All in the high risk group +
4. 5HT-3A + Dexamethasone
4Chemotherapy regimen with medium emetic risk (4 Options)
1. 5HT-3A
2. Dexamethasone
3. Prochlorperazine
4. Metoclopramide
5VTE in patients with cancer
LMWH
6Patient stopping anticoagulant post unprovoked DVT or PE
ASA if no C/I
7VTE in patients without cancer
Dabigatran, Xaralto, Eliquis or Edoxaban
8PCI with risk or Hx of HIT
Argatroban & Bivalirudin
9Anticoagulant in pregnancy
Warfarin
10Pre-meds for taxanes
H2RA + CCS (~ Dexa) + Diphenhydramine (Due to BBW hypersensitivity rxn caused by Chremephor in solvent)
11Heparin Induced Thrombocytopenia
Argatroban (IV)
(HIT Dx: Unexplained platelet drop >50% baseline
12DOC after HIT has resolved
Warfarin (Resolved when platelets > 150,000)
13Antipsychotic in Parkinsons patient
Quetiapine
14Depression in Parkinsons patient
Tricyclic - preferably seconadry amines
(desipramine or nortryptiline)
15Bipolar with depression
Lamotrigine (not effective for acute mania)
16Bipolar pregnant patient
Latuda (Lurasidone)
17Bipolar manic patient
Valproate OR lithium + antipsychoticx
18Premmenstrual dysphoric disorder
Prozac or Zoloft
19Treponema palladium (Syphilis)
PCN G Benzathine (Bicillin L-A)
2.4 million units intramuscularly x 1 dose
(BBW: IV can cause death)
20Neuroleptic Malignant Syndrome
1.Taper off antipsychotic
2.Cardio-resp, heme, & e-lyte support
3. Cooling bed & antipyrretics
4. BZD or Dantrolene or Bromocriptine
21Xyrem
(4-hydroxybutanoic acid aka Sodium oxybate)
Narcolepsy with cataplexy
22Dystonias (EPS SE)
Centrally acting anticholinergic
Benztropine or Diphenhydramine
23Akathisia (EPS SE)
Anticholinergics
Propranolol
BZD (Lorazepam last line)
24Tardive Dyskinesia
Can only try other agent - best quetiapine or clozapine
25Febrile neutropenia
Merrem
26Otitis media
Amoxicillin 80-90 mg/kg/day
or
Augmentin 90 mg/kg/day
27Reduce mucositis and myelosuppression after High Dose MTX
Leucovorin (Fusilev)
*Required if dose > 500mg/m2
28C. krusei and C. glabrata
Caspofungin
29Endocarditis PFX before dental procedures
Amoxicillin
2 grams PO x 1 dose
30Tick-borne/Rickettsial Diseases
Doxycycline
31MRSA
Vanco
*Consider different agent if MIC >/= 2 mcg/mL
32PFX Cardiac or vascular surgery
Cefazolin (1G) or cefuroxime (2G)
*BL allergy: Vanco or Clinda
33PFX hip fracture repair/total joint replacement
Cefazolin
*BL allergy: Vanco or Clinda
34PFX Colorectal & hysterectomy
Cefotetan or Cefoxitin (2Gs)
BL allergy: Clinda + (AMG or FQ or AZA)
or
Flagyl + (AMG or FQ)
35Prevention of neurological complications of meningitis
Dexamethasone 15-20 min prior to 1st dose of abx
36CA Acute bacterial meningitis in age < 1 month
Ampicillin* + Cefotaxime or Gentamicin
*Ampicilln for listeria coverage
37CA Acute bacterial meningitis in age 1-23 months
Cefotaxime or Ceftriaxone + Vancomycin
38CA Acute bacterial meningitis in 2-50 years
Cefotaxime 2g IV Q4-6H or Rocephin 2g Q12H
+
Vanco 30-45 mg/kg/day in divided doses
(Adult doses)
39CA Acute bacterial meningitis in > 50 years or immunocompromised
Vanco + ampicillin* + (Rocephin or cefotaxime)
40CA Acute bacterial meningitis in Pt. with severe PCN allergy
Moxi or Levofloxacin + Vanco (with or without Bactrim for listeria coverage)
41Acute otitis media
Amoxicillin 80-90 mg/kg/day Q12H
Augmentin 90mg/kg/day Q12H
42AOM w/ PCN allergy
Cefdinir, Cefuroxime, Cefpdoxime, or Ceftriaxone
43AOM prevention
Prevnar 13 starting at 2 mo of age
Influenza starting >/= 6mo of age
44Sinusitis
Augmentin
Adults x 5-7 days
Children x 10-14 days
45Acute sinusitis > 7-10 Days
Doxycycline 100mg PO BID x 5-7 days
46Pertussis (3 options)
1. Azithromycin 500mg x 1, then 250 mg QD x 2-5 days
2. Clarithromycin 500 mg BID or 1g ER x 7 days
3. Bactrim DS 1 tab BID x 14 days
47Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)
Augmentin x 5-10 days
48Outpatient CAP in Pt. with no ABX use in past 3 mo & previously healthy
Macrolide or doxycycline x 5 days
49Outpatient CAP in Pt. with risk for drug resistant S.pneumoniae
1. ABX use past 3 mo
2. Chronic diseases: <3, lung, liver, renal, DM, -OHism, malignancies & asplenia
3. Immunocompromised
Two options:
1. Cefpodoxime or Cefdinir + Macrolide or doxycyclnie
2. Respiratory FQ monotherapy (G,L,orM)
x 5 days
50Inpatient CAP
Two options:
1. BL + macrolide OR doxycycline
*Preferred BL: Ceftriaxone or Cefotaxime
*Preferred macrolide: Azithromyin
2. FQ Monotherapy (G, M, or L)
x 5 days
51Inpatient HAP & VAP with no/low risk of MDR pathogens (target MSSA & PsA)
Zosyn
Cefepime
Levaquin
Primaxin or Merrem
x 7 days
52Inpatient HAP & VAP targeting PsA & MRSA with no MDR risk factors
Zosyn
AZA
Cefepime
Levofloxacin
Primaxin, Merrem
+ Vanco or Linezolid
x 7 days
53Scabies (mites)
Elimite
(Cream formulation of permethrin)
54Urticaria (OTC & Rx)
OTC: 2G antihistamine e.g. Diphenhydramine
Rx: Hydroxyzine (Vistaril)
55Lice
Pyrethrins (Permethrin)
56HPV infection
Imiquimod (Aldara, Zyclara)
Inpatient HAP with high risk mortality or ABX within past 90 days
or
57Inpatient VAP with MDR risk factors or >10% resistance to monotherapy
(Choose 2, avoid 2 BL's)
Zosyn
AZA
Cefepime, Ceftazidime
Levofloxacin
Primaxin, Merrem
Tobramycin, gentimicin, amikacin*
Colistin, polymyxin B*
+ Vanco or linezolid
x 7 days
58Latent Tb INH treatment
INH x 9 mo. Preferred for HIV+, pregnant, & children
Rifampin x 4 month
INH and Rifapentin (Priftin) once weekly x 12 weeks
59Active Tb
Rifampin: 10mg/kg QD
INH: 5mg/kg QD + 25 mg PO Pyridoxine
Pyrazinamide
Ethambutol
Give entire regimin x 8 weeks. If Pt. susceptible to INH and RIF d/c P&E and continue INH & RIF for 4 months
60Endocarditis Streptococci viridans group
PCN, ampicillin, or rocephin +/- gentimicin for synergy
BL allergy: Vancomycin
61Endocarditis Staph MSSA Endocarditis
Nafcillin or cefazolin
BL allergy: Vanco (+ gentamicin if PV)
62Endocarditis Staph MRSA
Vanco (+ gentamicin if PV)
63Endocarditis Enterococci
PCN or ampicillin + gentamicin for synergy
BL allergy: Vancomycin
64IE Dental Prophylaxis
Amoxicillin 2 grams PO x 1 dose
PCN allergy: Clindamycin 600mg or
Azithro or clarithromycin 600mg
PCN allergy and NPO: Clindamycin 600mg IM/IV
65SBP
(PEK)
Rocephin x 5-7 days
66Mild NP SSTI (Target Streptococci)
PCN VK
Keflex
Dicloxacillin
Clindamycin
PO thx x 5 days
67Moderate NP SSTI (Target Strep & MSSA)
PCN
Rocephin
Cefazolin
Clindamycin
IV thx x 5 days
68Severe or necrotizing SSTI
Vanco + Beta lactam (Zosyn, Primaxin, or Merrem)
Necrotizing fascitis
69(Target Strep pyogenes)
PCN G + Clindamycin
70Moderate Purulent SSTI (Target CA MRSA)
Bactrim DS BID
or
Doxycycline 100 mg BID
+ I/D
71Acute uncomplicated cystitis
Nitrofurantoin 100 mg BID w/ food x 5d
or
Bactrim 1 DS tab BID x 3d
or
Fosfomycin 3g 1 dosein 40z H20
72Acute uncomplicated pyelonephritis in outpatient
FQ-R < 10%: PO Cipro x 7d or PO Levo x 5d
FQ-R > 10%: Rocephin 1g IV x1 or AMG IV x 1 then PO BL x 14 days
73Acute uncomplicated pyelonephritis in hospitalized patient
Initial IV then step down to PO and treat for 14 days total
74Bacteruria in pregnant woman
Augmentin or PO Ceph x 3-7 days
75Urinary analgesic
Phenazopyridine
200mg x 2 days
*Take with food & 8oz H20
76Mild-moderate CDI
1st infection
Flagyl 500mg PO TID x 10-14 days
77Mild-moderate CDI
2nd infection (1st Recurrence)
Flagyl 500mg PO TID x 10-14 days
(same as first time therapy)
78Mild-moderate CDI
3rd infection (2nd recurrence)
Vanco taper pulse therapy:
125 mg PO -
QID x 10-14 days
BID x 1 week
QD x 1 week
then, 125mg Q2-3d/wk x 2-8wks
79Severe uncomplicated CDI
1st infection
Vanco 125 mg PO QID x 10-14 days
80Severe uncomplicated CDI
2nd infection
Vanco 125 mg PO QID x 10-14 days (Same as first)
81Severe uncomplicated CDI
3rd infection
Vanco pulse/taper therapy
82Severe complicated disease
Vanco 500 mg PO QID + Flagyl 500 mg IV Q8H
or
*If complete ileus: Vanco per rectum 500mg in 100mL NS Q6H
83Severe complicated disease
2nd Infection
Vanco 500 mg PO QID + Flagyl 500mg IV Q8H
84Severe complicated disease
3rd infection
Vanco taper/pulse therapy
85Travelers diarrhea for pregnant and children
Azithromycin 1000mg PO x1 or 500mg PO QD x 1-3 days
861° or 2°Syphilis (<1 yr)
Bicillin L-A!!! (PCN G BENZATHINE)
2.4 million units IM x 1
873° Latent syphilis (>1 yr)
Bicillin L-A
2.4 million units IM x Qwk x 3
*If pregnant desensitize and use PCN*
88Gonorrhea
Rocephin 250 mg IM x 1 (Use Suprax 400mg PO x 1 if no Rocephin)
+
*Azithromycin 1 gram PO x 1
or
Doxycyclnie 100mg PO BID x 7 days
If using Suprax do cure test in 1 wk
:) This tx also covers chlamydia
89Chlamydia
Azithromycin 1 gram PO x1
*Preferred for pregnancy too
90ESBL infections
Carbapenems
91Hypercalcemia of Malignancy
Hydration + IV bisphosphonate (Zometa)
92Palmar-plantar erythrodysesthesia aka Hand-Foot Syndrome
No medications
93Aspergillus
Voriconazole
94Xerostomia
Pilocarpine (Salagen) (PO agent so can be difficult)
95Zygomycetes
Posaconazole
*PO preferred, must be with food
96Localized mild candida albicans (thrush) infections
Clotriamazole & Nystatin
97Moderate-severe candida albicans (thrush) infections or HIV+
PO Fluconazole
98Esophageal infection
Fluconazole or echinocandin
99Invasive fungal bloodstream infection
Echinocandin
100Nail infections
Terbinafine
101Cryptococcus neoformans
Induction: AmphoB + flucytosine
Consolidation: Fluconazole
102Influenza (TRMT & PFX)
Oseltamivir
TRMT: 75 mg BID x 5 days
PFX: 75mg QD x 10 days
Effective when started within 48 hour of illness.
Must be >/= 12 yo
103Relenza Diskhaler (TRMT & PFX)
Zanamivir: Neuramidase inhibitor inhaler
(1 inhalation = 5mg)
TRMT: >/=7 yo: 10 mg BID x 5 days
PFX >/=5 yo: 10mg QD x 10 days (household) or if community outbreak x 28 days
104Rapivab
Peramivir: Neuramidase inhibitor injectiono
600 mg IV 1xdose
*Can cause weird behavior
105Genital herpes (HSV-2)
Acyclovir 400 mg PO three times daily (or 200 mg 5x/day)
OR Valtrex 1 g PO twice daily
OR Famvir 250 mg PO TID.
The duration of HSV-2, first episode, should be 7-10 days.
106HSV encephalitis
IV acyclovir 10 mg/kg/dose Q8H x 14-21 dats
107Shingles
Zovirax, Famvir, or Valtrex
108CMV
Ganciclovir or valgancyclvoir
G: TRMT: 5mg/kg IV BID, 2PFX 5mg/kg IV QD
V: TRMT 900 mg PO BID x 21 d, 2PFX 900 mg PO QD
109EBV (mono)
No treatment
110OI: PCP
Bactrim DS PO QD x 21 days
*Dapsone if sulfa allergy. If giving with pyrimethamine add leucovorin to decrease myelosuppression
111OI: T.gondii
Bactrim DS tab Daily
*Same alternative as PCP if sulfa allergy
112OI: T.gondii encephalitis
Pyrimethamine + leucovorin +/- sulfadiazine
113OI: MAC
Azithromycin 1,200mg PO Qwk
or
Azithromycin 600mg twice weekly
or
Clarithromycin 500 mg PO BID
+ Ethambutol
114OI: Candidas
Fluconazole
116OI: 2°PFX cryptococcal meninigitis
Low dose fluconazole
117OI: 2°PFX CMV
low dose valganciclovir
118OI: 2°PFX MAC
same as treatment regimens
119Low-risk patient with febrile neutropenia
PO anti-pseudomonal agents (3 options)
1. Cipro + Augmentin
2. Cipro +/- Clindamycin
3. Levofloxacin
120High risk patient with febrile neutropenia
IV anti-PsA antibiotics (5 options)
1.Cefepime
2.Ceftazidime
3. Zosyn
4.Imipenem-cilastin
5.Merrem
121OI: 2°PFX PCP
Bactrim or dapsone depending on sulfa allergy
122HIV (6)
INSTI based:
Triumeq
Truvada
Descovy
Genvoya
Stribild
PI-Based:
Darunavir + ritonavir + truvada
123PrEP
Truvada 1 tab PO QD
124nPEP
Truvada + Dolutegravir or Raltegravir
PI-based:
Truvada + Darunavir
within 72 hours, x 28 days
125PEP
Isentress + Truvada
Within 72 hours, x 28 days
126HIV for pregnant women
2 NRTI + boosted-PI or INSTI
NRTI: Epzicom, Truvada, or Lamivudine
PI: Atazanavir or darunavir + ritonavir
INSTI: Raltegravir
127Moderate-Severe Rhinitis
ICS
128Moderate-Severe Rhinitis in pregnant woman
Budesonide (Rhinocort)
129Bacterial Vaginosis
*Flagyl 500mg PO BID x 7 days
or
*Flagyl 0.75% gel 5g intravaginally QD x 5 days
or
Clindamycin 2% cream 5 g intravaginally HS x 7 days
130Trichomoniasis
Flagyl (Or tinidazole) 2 grams PO x 1
*Use same for pregnancy
131Rocky Mountain Spotted Fever
Doxycycline 100 mg PO/IV BID x 5-7 days
*Would use in child in this case*
132Typhus
Doxycycline x 7 days
133Lyme Disease
Doxycycline x 10-21 days
or
Amoxicillin or cefuroxime x 14-21 days
134Pregnant - Rescue Inhaler
Albuterol
135Pregnant - ICS
Budesonide
136COPD Patient group A
SABA or LABA
137COPD Patient Group B
LABA or LAMA
138COPD Patient Group C
LAMA
139COPD Patient Group D
LABA + LAMA
141BP in Diabetics
ACE or ARB
143Addisons Disease
Fludrocortisone
144Desired pregnancy after discontinuation of Leflunomide (Arava)
Cholestyramine
145RA
Methotrexate (+DMARD after bridge in moderate/severe dz)
146SLE
Hydroxychloroquine +/- prednisone (or methylprednisonsolone) +/- Cytotoxic agent
147MS
Copaxone +/- Interferon-beta agent
148Raynauds
Nifedipine (DHP)
(Procardia, adalat)
149Psoriasis
Tazorotene & Calcipotriene
150Pressor in septic shock
Norepinephrine 0.1-1.3 mcg/kg/min
151Extravasation
Phentolamine
152Delirium in hospitalizatoin
Queitiapine
153Pregnant: Morning sickness. N/V
Lifestyle
Pyridoxine (B6) +/- doxylamine
155Pregnant: Flatululance
Simethicone
156Pregnant: Constipation
Fiber
(Psyllium, Calcium polycarbophil, methylcellulose)
+ Lots of fluids
157Pregnant: Cough, cold, & allergies
Chlorpheniramine (1G antihistamine)
Chronic allergy: Budesonide or Beconase AQ
*Important to use the inhaled in the first trimester*
158Pregnant: General infection
Amoxicillin & ampicillin
Cephalosporins
Erythro & Azithromycin
159Pregnant: Vaginal Fungal Infections
Topical OTC antifungals x 7 days
160Pregnant: UTI
Keflex: 600mg PO Q6H x 7 day
or
Ampicillin 500mg PO Q6H x 7 days
161Pregnant: Hyperthyroidism
Levothyroxine
Must increase dose by 30-50%
162Pregnant: HTN
Labetalol
Methyldopa
Nifedipine
163Diabetes
Metformin
Insulin
Glyburide
164PCOS & Endometriosis
Combination oral contraceptives (COC)
165Moderate-severe vasomotor symptoms in postmenopausal women
Duavee
Conjugated Estrogens & Bazedoxifene
166Osteoporosis treatment and PFX
Bisphosphonates
167Osteoporosis with HIGH RISK FRACTURE
Teriparatide (Forteo)
168Topical 17-Beta-Estradiol HT (3 formulations)
Cream: Estrace - to be inserted in vagina
Ring: Estring - Q3mo
Foam: Vagifem
169PO 17-Beta Estradiol HT
Estrace
170Conjugated Equine Estrogens & medroxyprogesterone
PremPro & Premphase
171Estradiol patch
Once weekly
Menostar
Climara
Given Twice Weekly:
Minivelle
Vivelle-dot
Alora
173Conjugated Equine Estrogens (3 formulations)
Premarin
Tablet, vaginal cream, and injection
174Brisdelle
Paroxetine
For dysparenunia
176Breast CA in pre-menopausal women
Tamoxifen
177Breast CA in post-menopausal women
Aromatase Inhibitor
178Metastatic prostate cancer
Chemical castration
Gonadotropin release hormone agonist or antagonist
179Chronic Myelogenous Leukemia (CML)
BCR-ABL
(Imatinib, dasatinib, nilotinib)
180Melanoma
BRAF inhibitors, often in combination with MEK 1 and 2 inhibitors
181Anaplastic Lymphoma Kinase Inhibitors
Crizotinib (ALK inhibitor)
182Non-small Cell Lung Cancer
EGFR inhibitors
183Metastatic breast cancer
Palbociclib with fulvestrant or letrozole
(Ibrance + Faslodex)
184Acute-Acid Promyelocytic Leukemia
Tretinoin
185Extravasation due to adriamycin
Cold compress & IV Totect
186Extravasation due to mitomycin
Cool compress & DMSO (dimethyl sulfoxide)
187Acute cholinergic symptoms due to Irinotecan(Flushing, diaphoresis, abdominal cramping, diarrhea)
Atropine
188Delayed diarrhea with Irinotecan
Loperamide
*UGT1A1*28 at increased risk (also for neutropenia)
189Post menopausal symptoms (esp. hot flashes) from SERM therapy
Venlafaxine
190Overactive Bladder
Kegel exercises 3x/wk
191Mild Chrons Disease
PO Budesonide
192Mild UC
Mesalamine (5-ASA) rectal &/or PO preferred
193Secondary prevention for patient with noncardioembolic stroke or TIA
Anti-platelet therapy:
3 options
1. Aspirin
2. Aspirin + ER dipyridamole
3. Clopidogrel
194Secondary prevention for patient with cardioembolic stroke
Anti-coagulation therapy
195TRMT of subarrachnoid hemmorage (SAH)
Nimodipine (Nymalize)
-highly lipophilic specific to blood vessels
-Good to pierce and squirt medication into pt mouth
-Use up to 21 days
DO NOT USE IV
196Acne
Retinoid Topicals
(e.g. Atralin, Renova, Retin-A)
197Severe recalcitrant nodular acne
PO isotretanoin
*causes a lot of dryness. hydrate, lip balm, eye drops*
198Alopecia
Finasteride
Propecia
OR
Minoxidil topical OTC
199Dandruff
Suave "dandruff"
200Diaper rash prevention
Petrolatum ointment w/ zinc oxide
e.g. Desitin
201Eczema
Topical steroids & HYDRATION
202Tinea pedis, cruris, or corporis
Topical antifungal
203HTN in non-black +/- DM (4 options)
Thiazide
CCB
ACE
ARB
204Black +/- DM (2 options)
CCB
Thiazide
205CKD +/- albuminuria +/- DM
ACE or ARB
206HTN in pregnancy (3 options)
Methyldopa
Labetalol
Nifedipine ER
207HF patient with arrhythmia
Amiodarone
208Control ventricular rate in a patient presenting in atrial fibrillation with a rapid ventricular response
Digoxin
209PFX nephrotoxicity due to cisplatin
Amifostine (Ethyol)
210DM in pregnancy
lifestyle and diet modifications are recommended first, if still inadequate, insulin is tx of choice
Fasting <=95
1 hour post-meal =<140
2 hour post meal = <120
211S/sx DM
Polyuria
Polyphagia (excessive hunger)
Polydipsia (excessive thirst)
Blurred vision
Fatigue
212A1C to eAG
A1c of 6 is approximately 126 mg/dL
each 1% increase in A1c is equal to about 28 mg/dL
(A1c-2) x30
213Drugs that induce hyperglycemia
Beta blockers
Diuretics
Immunosuppressants
Niacin
Protease inhibitors
Quinolones
Atypical antipsychoics
Statins
Systemic steroids
214ADA adult non-pregnant treatment goals
A1c <7
Preprandial glucose 80-130
Postprandial glucose <180
215Monotherapy
Lifestyle modifications + metformin
* if A1c >9 consider starting with dual therapy
*if A1c >10 and BG >300 consider stated with combination injectable therapy
216Dual therapy
Choose one to add on:
SU
TZD
DPP-4 inhibitor
SGLT2 inhibitor
GLP-1 agonist
Basal insulin
217Triple therapy
Most 3 drug combinations are acceptable
DO NOT USE: due to lack of studies or similar MOA
Metformin + DPP-4 + GLP-1 agonist
Metformin + SU + basal insulin
If still not working switch to injectables or add basal insulin
218Drugs that increase/ replace insulin secretion
Insulin
SU
Meglitinides
219Drugs that decrease hepatic glucose output
Metformin
220Decrease glucagon which decreases glucose production
GLP-1 agnoists
DPP4-inhibitors
Pramlinitide
221Drugs that slow gastric emptying
GLP-1 agnoists
Pramlinitide
222Drugs that increase glucose secretion
SGLT2 inhibitors
223Drugs that increase insulin sensitivity
TZDs
Metformin
224Janumet
Metformin + sitagliptin
225Qtern
Saxagliptin/dapagliflozin
226Xultophy
Liraglutide/insulin degludec
227Soliqua
Loxisenatide/insulin glargine
228Metformin
Biguanide glass
Works by decrease glucose production, decrease absorption of glucose and increasing insulin sensitivity
1st line therapy in DM2
BBW: lactic acidosis, renal impairment w/ contrast dyes
C/I: eGFR <30
Do not initiate if eGFR 30-45
Monitor renal function
ER formulations can leave ghost tablet in stool
Give with a meal to decrease GI upset, N/V/D, flatulence, abdominal cramping
229Metformin D/Is
Alcohol can increase risk for LA
Contrast media can increase risk of lactic acidosis, restarted 48 hours after procedure
230Insulin secretagogues
SUs
Meglitinides
Stimulate insulin secretion from pancreatic beta cells to decrease postprandial blood glucose
Meglitinides have faster onset (15-60 minutes) and shorter DOA and require multiple daily dosing
231Meglitinides
Repaglinide (15-30 minutes before meal)
Nateglinide (1-30 minutes before meal)
Warnings: hypoglycemia
SEs: weight gain
232Sulfonylureas
Glipizide (glucotrol)
Glimepiride (Amaryl)
Glyburide
Warnings: hypoglycemia
SEs: weight gain, nausea
Glipizide IR is taken 30 minutes before a meal all others can be taken with breakfast, hold dose if pt NPO
Glucotrol XL can leave ghost tablet in stool
Glyburide is renally cleared, not preferred in renal insufficiency
233SU/Meglitinide D/Is
Insulin, SU, and meglitinides should never be used in combination due to risk of hypoglycemia
234Thiazolidinediones
PPAR-gamma agonists that cause increase in peripheral insulin sensitivity
Pioglitazone (actos)
Rosiglitazone)
C/I: Class 3/4 heart failure
Warnings: hepatic failure, edema
Pioglitazone: increase risk of urinary bladder tumors, do not use in pts with active bladder cancer
SEs: peripheral edema, weight gain
235SGLT2 inhibitors
Reduce reabsorption of filtered glucose (increasing urinary glucose excretion)
Canagliflozin (invokana)
Dapagliflozin (farxiga)
Empagliflozin (jardiance)
BBW canagliflozin: increase risk of leg and foot amputations
C/I: eGFR <30
Warnings: ketoacidosis, genital mucotic infections, urosepsis, pyelonephritis, hypotension due to AKI, canagliflozin can cause hyperkalimia
SEs: weight loss
236SGLT2 D/Is
Increased risk of intravascular volume depletion causing hypotension and AKI hen used with a diuretics, RAAS inhibitors or NSAIDS
Monitor K closely in pts on cana
237DPP4 inhibitors
Prevent enzyme DPP-4 from breaking down incretin hormones (like GLP-1) and increase insulin release and decrease glucagon secretion
Sitagliptin (januvia)
Saxagliptin
Linagliptin
Alogliptin
Warnings: acute pancreatitis, risk of HF (saxa and alo)
Lina does not require renal dose adjustments
238Alpha glucosidase inhibitors
Acarbose
Miglitol
Inhibit metabolism of intestinal sucrose which delays glucose absorption
Does no cause hypoglycemia but if a pt becomes hypoglycemic cannot treat with sucrose, MUST use glucose tablets or gel
Take each dose with 1st bite of meal
GI side effects are common
239Bile acid binding resins
Colesevelam
Constipation is most common side effect
Also used for hyperlipidemia
240Dopamide agnoists
Bromocriptine
Inhibits lactation (c/i in those breastfeeding)
Do not use with other dopamine agonists
241GLP1 agonists
Analogs of GLP-1 which increase glucose dependent insulin secretion and decrease glucagon secretion
Exenatide (BID) & Exenatide ER (weekly)
Liraglutide (victoza) --> daily
Dulaglutide (trulicity) -->weekly
Albiglutide (tanzeum)--> weekly
Lixisenatide (adlyxin) --> daily
Warnings: pancreatitis, not recommended in pts with severe GI disease
SEs: nausea, weight loss
Slow gastric emptying and can decrease extent and rate of absorption of orally administered drugs
Can increase INR in pts on warfarin
242Pramlinitide
Synthetic analog of amylin which helps control postprandial glucose by slowing gastric emptying
Can use in type 1 and type 2 DM
Admin SC prior to each meal
BBW: severe hypoglycemia
C/I: gastroparesis
Warnings: hypoglycemia (reduce meal time insulin by 50% when starting)
SEs: N/V, anorexia, HA, weight loss
243Physiologic functions of insulin
Convert glucose into glycogen
Helps muscle cells take up glucose
Converts excess glucose to fat for storage in adipose tissues
244Rapid acting insulins
Aspart (novolog)
Lispro (humalog)
Afrezza (oral inhalation powder)
Aspart/lispro
--> hypoglycemia, hypokalmia
-->SEs weight gain
Afrezza:
-->BBW acute bronchospasm
--> C/I in asthma/COPD
--> replace inhaler every 15 days
Onset within 30 minutes, peak around 1 hr, duration only a few hours
245Short acting insulins
Regular insulin (humulin R, novolin R)
Concentrated regular insulin (U-500)
Regular: can be used in IV solutions, available w/o a prescription
U-500: 5 times as concentration (500 units/mL)
--> all pts using must be prescribed a u500 syringe, each marking represents 5 units and no dose conversions are needed
--> do not mix with any other kind of insulin
Onset within 30 minutes, peak around 3-4 hours, duration up to 12 hours
246Intermediate acting
NPH insulins (humulin N, novolin N)
Same as rapid acting insulins plus:
Cloudy in color
Available without a prescription
Can mix with rapid or short acting insulins (clear before cloudy)
Onset within a couple hours, peak around 10 hours, duration up to 24 hours
247Long-acting insulins
Detemir (levemir)
Glargine (Lantus)
Same as rapid acting insulins above
Onset within 4 hours, no peak, duration >24 hours
248Pre-mixed insulins
70/30, 75/25, 50/50 (higher percent longer acting)
Given BID w/ meals according to rapid/short acting component
Humulin and novolin 70/30 are available without a prescription
NPH and protamine are cloudy
249Initiating insulin in new type 1 TDD
TDD = 0.6 units/kg/day based on actual body weight
Divide in 2 to get basal and bolus insulin
Divide bolus insulin into 3 meals
IF using NPH and regular use 2/3 of TDD as NPH and 1/3 as regular insulin dose
250Insulin to carb ratio (rule of 500 and 450)
Rule of 500 (rapid acting insulin)= 500/TDD = g of carbs covered by 1 unit of rapid acting insulin
Rule 450 (regular insulin)= 450/TDD= g of carbs covered by 1 unit of regular insulin
251Correction factor/correction dose
Amount of insulin needed to return their blood glucose to a normal range (added to the dose they would normally take for that meal)
1800 rule (rapid acting)= 1800/TDD= correction factor for 1 unit for rapid acting insulin
1500 rule (regular)= 1500/TDD= correction factor for 1 unit of regular insulin
Correction dose:
(blood glucose now- target glucose)/ correction factor
252Insulin initiation in DM2 pt
Basal insulin 0.1-0.2 units/kg/day using actual body weight, or 10 units/day
Dose is titrated 10-15% once or twice weekly to reach astinng blood glucose control
253Insulin conversion
1:1 unit:unit conversion of TDD can be used in most cases (assuming good control)
BID NPH--> QD glargine use 80% of total NPH dose
Toujeo-->lantusasaglar use 80% of total daily toujeo dose
254Room temp stability
Afrezza- 3 days
10 days:
--humalog 50/50 and 75/25 pens
--humulin 70/30 pens
14 days
--humulin N pen
--novolog 70/30 pen
28 days
--apidra, humalog, novolog vials and pens
--humalog 50/50 and 75/25 vials
--Novolog 70/30 vial
-humulin U500 pen
--Lantus vial/pen, basaglar pen
30 days
--humulin R u100 and 70/30 vials
40 days
humulin r u500 vial
42 days
novolin R, N and 70/30 vials
Toujeo pen
levemir vial/pen
255Insulin pens
FlexPen: novlog products
KwikPen: humalog / humulin / basaglar
FlexTouch: levemir and tresible
SoloStart: lantus and toujeo
256Hypoglycemia
lesss than <70 mg/dL
257Treatment
15-20 grams of glucose/simple carbs
recheck BG in 15 minutes
If persists, repeat step 1
Once back to normal patient should eat small snack or meal
258DKA
Type 1 diabetics
BG >250
Ketones in urine
Anoin gap metabolic acidosis
259DKA treatment
-Fluids (start with NS when BG <250 change to D5W1/2NS)
-Regular insulin infusion (0.15 units/kg bolus then 0.1 units/kg/hr)
-Monitor potassium to prevent hypokalemia
-Give sodium bicarb if needed
260HHS
Type 2 DM
Serum ketones are not present because DM2s have enough insulin to suppress ketogenesis
BG >600
Extreme dehydration
Altered consciousness
261Drugs with biggest decrease in A1C
Insulin
Metformin
SUs
TZDs
GLP-1 agonists
262Common resistant pathogens
Klebsiella pneumoniae (ESBL, CRE)
Escherichia coli (ESBL, CRE)
Acinetobacter baumanii
Enterococcus faecalis, Enterococcus faecium (VRE)
Staphylococcus aureas (MRSA)
Pseudomonas aeruginosa
263CYP inducers
PS PORCS: phenytoin, smoking, phenobarbital, oxcarbazepine, rifampin, carbamazepine, St. John's wort
264CYP inhibitors
G PACMAN: grapefruit, protease inhibitors, azole antifungals, cyclosporine (also cimetidine, cobicistat), macrolides (clarithro, erythro), amiodarone, non-DHP CCBs (diltiazem and verapamil)
265List of approved drugs that can be interchanged with generics based on therapeutic equivalence
Orange Book (FDA)
266Information on epidemiology and vaccine-preventable diseases
Pink Book (CDC)
267News reports on regulatory, legislative, legal and business developments
Pink Sheet (Pharma Intelligence)
268List of biological drug products, including biosimilars
Purple Book (FDA)
269Drug pricing information
Red Book, Pharmacy
270Summaries of pediatric infectious diseases, antimicrobial treatment and vaccinations
Red Book, Pediatrics (AAP)
271Information of the health risks of international travel, required vaccines and prophylaxis medications
Yellow Book (CDC)
272Information on approved animal drug products
Green Book (FDA)
273Drugs with leaching/adsorption issues with PVC containers
Lorazepam, Amiodarone, Taxanes, Tacrolimus, Insulin, Nitroglycerin
274Only compatible in saline
("A DIAbetic Can't Eat Pie")
Ampicillin, Daptomycin, Infliximab, Amp/Sulbactam, Caspofungin, Ertapenem, Phenytoin
275Only compatible in dextrose
("Obese Bakers Avoid Salt")
Oxaliplatin, Bactrim, Amphotericin B, Synercid
276Common drugs with filter requirements
*Pushy Guys (and gals) in LA LA land*
*P*henytoin
*G*olimumab
*L*ipids (1.2 micron - larger pore size filter required)
*A*mphotericin B (lipid formulations - prepare using 5 micron filter)
*L*orazepam
*A*miodarone
*Most require 0.22 micron filter during administration*
Additional drugs: *Isavuconazonium*
277Do not refrigerate
(Dear Sweet Pharmacist, Freezing Makes Me Edgy)
Dexmedetomidine, SMX/TMP, Phenytoin, Furosemide, Moxifloxacin, Metronidazole, Enoxaparin
278Protect from light during administration
(Protect Every Necessary Med from Daylight)
Phytonadione, Epoprostenol, Nitroprusside, Micafungin, Doxycycline
Others: Ampho B Deoxycholate, Anthracyclines, Dacarbazine, Pentamidine, Thiotepa
279Continuous data
ratio or interval data:
ratio - age, height, weight, time BP
interval - Celsius or F temp scales
280Discreet data
also categorical data:
nominal - gender, ethnicity, marital status, mortality
ordinal - NYHA Functional Class, pain scale
281Type I error
false positive, the incorrect rejection of a null hypothesis, related to alpha level
found a difference when there actually is not one
282Type II error
false negative, incorrectly accept the null hypothesis
not finding a difference when there actually is one
283study power
The ability to detect a difference btw study groups if one actually exists.
*Indirectly related to the likelihood of making a Type II (b) error*...As power increases, chance of type II error decreases
284interpretation of 95% confidence interval
We are 95% confident that the true population value lies somewhere between ___ and ___ (range).
285interpretation of NNT 45
For every 45 patients who receive [treatment] for [one year], [outcome (e.g. HF progression)] is prevented in one patient
(*ROUND UP NNT* so you don't overestimate benefit)
286interpretation of NNH 90
One additional case of [major bleeding] is expected to occur for every 90 patients taking [drug] instead of [placebo/other drug].
(*ROUND DOWN NNH* so you don't underestimate harm)
287What kind of statistical analysis should be performed for continuous data that is normally distributed between a single group compared to known data from the population?
one-sample t-test
288What kind of statistical analysis should be performed for before and after continuous data that is normally distributed between a single group?
dependent/paired t-test
289What kind of statistical analysis should be performed for continuous data that is normally distributed between two groups (e.g. treatment and control comparison for BP reduction)?
unpaired student t-test
290What kind of statistical analysis should be performed for continuous data that is normally distributed between three or more groups?
ANOVA
291What kind of statistical analysis should be performed for discreet/categorical data between a single group or two groups (e.g. mortality data)?
Chi-square test
(Fisher's exact for a very small trial)
292Cost-minimization analysis
used when two or more interventions have already demonstrated equivalency in outcomes and the costs of each intervention are being compared
293cost-benefit analysis
compares the costs and benefits between unrelated or related programs, as long as the outcome is monetary
294cost-effectiveness analysis
outcomes are measured in natural units (e.g. life years gained, mmHg blood pressure, % at treatment goal)
295cost-utility analysis
measured in QALY
296What is the focus of USP <797>?
minimize the risk of microorganisms or other contaminants in sterile preparations
297What is the focus of USP <800>?
keep the compounder safe and reduce risk of exposure to the HD
298What are the physical space basics for non-sterile compounding?
*needs to be separate and distinct from any sterile compounding
*can be performed in ambient (room) air
*must have adequate space for orderly work with shelving and storage & no storage on the floor
*needs to be adequate plumbing and 2 types of water: potable (tap water) to wash hands (along with soap and single-use towels or a hand dryer) and purified/distilled water for compounding and rinsing equipment
*well-lit, controlled HVAC, with temperature and humidity monitoring
299What are the physical space basics for sterile compounding?
*anteroom, buffer area and a PEC (hood) with specific ISO air requirements
*all surfaces must be smooth, impervious, free from cracks or crevices and non-shedding so they are easy to clean
*walls - locked, sealed panels
*floors overlaid with wide, sheet vinyl flooring with heat-welded seams
*buffer area cannot contain sinks or floor drains
*required air and surface sampling, temp and humidity requirements to test for contaminants
300What are the physical space basics for hazardous drugs?
*Containment*-PEC or SEC (vertical flow hood)
*permissible to perform both sterile and non-sterile HD compounding in same area as long as ISO 7 air is maintained, kept 1 meter apart, no HD powders at the same time as sterile compounding
*negative air pressure in C-SEC and C-PEC & externally exhausted or use redundant HEPA filters (* if non-sterile HD ONLY*)
*non-sterile HD ACPH 12/sterile 30